E-GEOD-42949 - Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells
Released on 22 July 2013, last updated on 2 June 2014
Understanding transcriptional changes during cancer progression is of crucial importance to develop new and more efficacious diagnostic and therapeutic approaches. It is well known that ErbB2 is overexpressed in about 25% of human invasive breast cancers. We have previously demonstrated that p130Cas overexpression synergizes with ErbB2 in mammary cell transformation and promotes ErbB2-dependent invasion in three-dimensional (3D) cultures of human mammary epithelial cells. Here, by comparing coding and non-coding gene expression profiles, we define the invasive signatures associated with concomitant p130Cas overexpression and ErbB2 activation in 3D cultures of mammary epithelial cells. Specifically, we have found that genes involved in amino acids synthesis (CBS, PHGDH), cell motility, migration (ITPKA, PRDM1), and angiogenesis (HEY1) are upregulated, while genes involved in inflammatory response (SAA1, S100A7) are downregulated. In parallel, we have shown that the expression of specific miRNAs is altered. Among these, miR-200b, miR-222, miR-221, miR-R210, and miR-424 are upregulated, while miR-27a, miR-27b, and miR-23b are downregulated. Overall, this study presents, for the first time, the gene expression changes underlying the invasive behavior following p130Cas overexpression in an ErbB2 transformed mammary cell model. To identify transcriptional changes occurring during invasion we have performed a comparative microarray analysis of non coding RNA (miRNA) between MCF10A.B2 acini over-expressing p130Cas with activation of ErbB2 and control cells.
transcription profiling by array
Cristiano De Pitta <email@example.com>, Alessandra Pincini, Daniela Taverna, Emilia Turco, Enzo Medico, Francesca Orso, Giusy Tornillo, Paola Defilippi, Paolo Provero, Sara Cabodi
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells. Pincini A, Tornillo G, Orso F, Sciortino M, Bisaro B, Camacho-Leal MD, Lembo A, Brizzi MF, Turco E, De Pittï¿½ C, Provero P, Medico E, Defilippi P, Taverna D, Cabodi S.